Clinical pathway for patients with chronic myeloid leukaemia: The euriclea project

Stefano Botti, Gianpaolo Gargiulo, Felice Bombaci, Giovanna Artioli, Chiara Cosentino, Adriana Concetta Pignatelli, Daniela Torino, Maria Marcella Lionetti, Emanuela Samarani, Lorella Cappucciati, Paola Bordiga, Antonella Diodati, Cristiana Caffarri, Irene Rosini, Fabrizio Pane

Research output: Contribution to journalArticle

Abstract

Background and aims: The use of Tirosine Kinase Ihnibitors (TKIs) for the treatment of Chronic Myeloid Leukemia (CML) has definitely represented a turning point in the treatment of the onco-hematological diseases. Over the years, the interest of physicians, nurses, patients and caregivers has increasingly focused on the aspects of the humanization of care, the management of side effects and on the full and constant therapeutic adherence. The aim of the project was to define patient-oriented care processes, based on a proactive approach that can fully respond to the new health needs of CML patients. Methods: A nursing expert Working Group (WG) was established. WG reviewed literature about CML patients assistance and then it was conducted a survey on organizational models for the treatment of CML patients, adopted by Italian haematologic and transplant centers. Finally, the main issues regarding CML patients care were identified and discussed on a multiprofessional basis. Results: Euriclea Project for care of CML patients with the description of a new and expanded nurse role was defined. The Nurse Case Manager or Nursing Clinical Experts were identified as key people for the management of the side effects of treatment, the promotion of the therapeutic adherence and the evaluation of efficacy and effectiveness of the process through the identification of specific indicators for structure, process and outcome. Discussion: The focal areas of the care process were identified so as to define a different approach to the CML patient, through a holistic view of care and the multidisciplinary interventions.

Original languageEnglish
Pages (from-to)5-12
Number of pages8
JournalActa Biomedica
Volume88
DOIs
Publication statusPublished - 2017

    Fingerprint

Keywords

  • Adherence
  • Adverse events
  • Chronic myeloid leukaemia
  • Clinical pathways
  • Nursing
  • Patient empowerment
  • Proactive care
  • Side effects
  • Tirosine chinase inhibitors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Botti, S., Gargiulo, G., Bombaci, F., Artioli, G., Cosentino, C., Pignatelli, A. C., Torino, D., Lionetti, M. M., Samarani, E., Cappucciati, L., Bordiga, P., Diodati, A., Caffarri, C., Rosini, I., & Pane, F. (2017). Clinical pathway for patients with chronic myeloid leukaemia: The euriclea project. Acta Biomedica, 88, 5-12. https://doi.org/10.23750/abm.v88i3-S.6608